Signaling through the well-known oncogene Ras can promote proliferation, cell survival, and differentiation and is implicated in cancer. Mutations that increase signaling through this pathway are found frequently in cancer and also occur in developmental disorders such as Noonan's Syndrome. Thus, it is vital to understand how Ras is regulated. Much attention has focused on understanding activation of this pathway at upstream steps, such as the binding of ligands to Receptor Tyrosine Kinases (RTKs), which act through other proteins to recruit and activate Ras. Recently, modification of Ras by a process called ubiquitination has been reported in mammalian cells. My research group now has data confirming the ubiquitination of Ras using Drosophila (fruit flies). This suggests that this newly discovered regulation of Ras is highly conserved. Moreover, using Drosophila (fruit flies) we generated compelling evidence that the ubiquitination of Ras has profound effects on growth, proliferation and cell survival. The powerful system of Drosophila genetics and the well-established paradigm of studying Ras in Drosophila make this an excellent system to address and characterize the significance of Ras ubiquitination in a multi-cellular context. Furthermore, an in vivo Drosophila approach has the potential to make significant and unique discoveries that would not be possible in other systems. The goal of this proposal is to use Drosophila to understand the biological role of Ras ubiquitination. Our hypothesis is that ubiquitination of Ras restricts its ability to promote growth and proliferation. Our hypothesis is based on our Drosophila findings that (1) Drosophila Ras is ubiquitinated, (2) impairing ubiquitination promotes increased signaling through Ras, and (3) impairing ubiquitination promotes Ras-dependent overgrowth, increased, proliferation, and cell death resistance that appear independent of steps upstream of Ras. The novelty of our findings is that Ras may be a distinct step in the pathway whose ubiquitination is crucial to ensure proper control of growth and proliferation. My research group will exploit our expertise in studying the ubiquitin pathway and in utilizing Drosophila to most efficiently attack this problem. The proposed studies perfectly complement ongoing molecular and tissue culture studies being performed elsewhere. In the short term, our studies could establish the biological significance of this novel regulation of Ras. Over the longer term, our work could contribute tremendously towards a better understanding of the Ras oncogene and may even identify therapeutic targets. Therefore, we believe that these studies could have profound implications for cancer research. We propose research according to the following Aims:
Specific Aim 1 : Establish the biological significance of Ras ubiquitination.
Specific Aim 2 : Examine Ras ubiquitination in vivo.
Specific Aim 3 : Identify and characterize the Ras E3.

Public Health Relevance

Mutations that activate a protein called Ras or that increase signaling through the Ras pathway are frequently found in developmental disorders and in cancer. Therefore, it is crucial that we understand how Ras signaling is regulated. The proposed studies will investigate a novel regulation of Ras by a process called """"""""ubiquitination"""""""" and could contribute tremendously towards a better understanding of Ras and may have profound implications for cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA140451-03
Application #
8038317
Study Section
Molecular Oncogenesis Study Section (MONC)
Program Officer
Watson, Joanna M
Project Start
2009-05-01
Project End
2014-02-28
Budget Start
2011-03-01
Budget End
2012-02-29
Support Year
3
Fiscal Year
2011
Total Cost
$327,878
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Reimels, Theresa A; Pfleger, Cathie M (2016) Methods to Examine the Lymph Gland and Hemocytes in Drosophila Larvae. J Vis Exp :
Jahanshahi, Maryam; Hsiao, Kuangfu; Jenny, Andreas et al. (2016) The Hippo Pathway Targets Rae1 to Regulate Mitosis and Organ Size and to Feed Back to Regulate Upstream Components Merlin, Hippo, and Warts. PLoS Genet 12:e1006198
Reimels, Theresa A; Pfleger, Cathie M (2015) Drosophila Rabex-5 restricts Notch activity in hematopoietic cells and maintains hematopoietic homeostasis. J Cell Sci 128:4512-25
Fagan, Jeremy K; Dollar, Gretchen; Lu, Qiuheng et al. (2014) Combover/CG10732, a novel PCP effector for Drosophila wing hair formation. PLoS One 9:e107311
Ilanges, Anoj; Jahanshahi, Maryam; Balobin, Denis M et al. (2013) Alcohol interacts with genetic alteration of the Hippo tumor suppressor pathway to modulate tissue growth in Drosophila. PLoS One 8:e78880
Liu, Hsiu-Yu; Pfleger, Cathie M (2013) Mutation in E1, the ubiquitin activating enzyme, reduces Drosophila lifespan and results in motor impairment. PLoS One 8:e32835
Pfleger, Cathie M (2011) Ubiquitin on ras: warden or partner in crime? Sci Signal 4:pe12
Wu, Kenneth; Yan, Hua; Fang, Lei et al. (2011) Mono-ubiquitination drives nuclear export of the human DCN1-like protein hDCNL1. J Biol Chem 286:34060-70
Pfleger, Cathie M; Wang, Jun; Friedman, Lauren et al. (2010) Grape-seed polyphenolic extract improves the eye phenotype in a Drosophila model of tauopathy. Int J Alzheimers Dis 2010:
Yan, Hua; Jahanshahi, Maryam; Horvath, Elizabeth A et al. (2010) Rabex-5 ubiquitin ligase activity restricts Ras signaling to establish pathway homeostasis in Drosophila. Curr Biol 20:1378-82

Showing the most recent 10 out of 12 publications